戻る Agenda
Session 6 : Development of Innovative Drug
Session Chair(s)
Heesung Kim, PHD
Director of Pre-Submission Consultation Division, NIFDS
MFDS, Korea, Republic of
Speaker(s)
Jun Park, PHD
ILIAS Biologics, Inc., Korea, Republic of
EVP/Chief Technology Officer
Hae-Young Ahn, PHD
Ahn Bio, United States
President
Youngju Choi, PHD
National Institute of Food & Drug Safety (NIFDS), Korea, Republic of
Director General of Biopharmaceutical & Herbal Medicine Evaluation Department